how glp-1 drugs cause gastroparesis lawsuits receptor agonists and delayed gastric emptying: implications for invasive cardiac interventions and surgery Ozempic Lawsuit for Gastroparesis |

9 SignalP analysis of the signal peptide region containing the GLP1R p.Pro7Leu variant

21,25 A recent communication from the European Medicines Agency's Pharmacovigilance Risk Assessment Committee indicated that the current evidence does not support a causal link between GLP-1 RA and thyroid cancer, nor does it warrant alterations to the product information

doi: 10.1124/pr.115.011395

When GLP-1 RAs are not used concomitantly with a sulphonylurea or insulin, routine glucose monitoring is unnecessary due to the low risk of developing hypoglycemia

Management Tips: Stay well-hydrated and avoid skipping meals

The OR for achieving a weight loss of at least 5% with tirzepatide 5 mg, 10 mg and 15 mg (vs GLP-1 RAs) was, respectively, 1.96 (95% CI 1.01, 3.80 [ I 2 61%]), 4.79 (95% CI 1.95, 11.73 [ I 2 74%]) and 4.57 (95% CI 3.38, 6.18 [ I 2 0%]) (ESM Table 2)